ClinConnect ClinConnect Logo
Search / Trial NCT03707691

Pitch Perception and Memory: Deficits and Training

Launched by HOSPICES CIVILS DE LYON · Oct 12, 2018

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Hearing Cochlear Implants Congenital Amusia Pitch Audio Visual Interactions

ClinConnect Summary

This clinical trial, titled "Pitch Perception and Memory: Deficits and Training," is looking at how people with cochlear implants, as well as individuals with a specific condition called congenital amusia (which affects the ability to perceive music), understand and remember different pitches in sounds. The researchers want to learn more about how these groups process sounds compared to people without hearing issues. They will use several methods, including behavioral tests and brain imaging techniques, to identify any challenges in pitch perception and to see if a training program can help improve these skills.

To participate in the study, adults aged 18 to 90 are eligible as long as they do not have significant neurological or psychiatric disorders and can follow study instructions. For younger participants, ages 5 and up, parental consent is required. All participants should be motivated to take part and be covered by social security. Those interested can expect to engage in various activities that measure their ability to recognize pitches, and they may also participate in training sessions aimed at improving their pitch perception. This study is currently recruiting participants, and it aims to better understand auditory processing, which is important for recognizing speech and music.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • For adult participants:
  • Aged between 18 and 90
  • Absence of neurological and psychiatric disorders
  • No major cognitive deficit, ability to understand and apply study instructions
  • Motivation to participate efficiently in the study
  • Written informed consent to participant in the study
  • Affiliated to social security
  • Control participants and participants with congenital amusia for Experiment 5: MRI/MEG compatibility
  • For underage participants:
  • Subject aged 5 years and over
  • Informed consent of parents or guardians for the participation of the child being studied
  • No neurological or psychiatric history
  • Without major cognitive impairment and ability to understand and apply setpoint.
  • Subject affiliated to a social security scheme
  • Motivation to participate effectively in the project
  • Exclusion Criteria:
  • For adult participants:
  • Age below 18 or above 90
  • Pregnant or breast-feeding woman
  • For underage participants:
  • - Pregnant or nursing minors

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Bron, , France

Patients applied

0 patients applied

Trial Officials

Anne CACLIN

Principal Investigator

Hospices Civils de Lyon

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials